Montag & Caldwell Growth Fund  (MCGIX)

I
  • N
  • I
Advisors: 800.368.4410
Investors: 800.548.4539

Fund Overview

Fund Overview

Share Class

I

  • N
  • I

NAV | as of 07/02/2020

$20.28
+$0.08 (+0.40%)

Morningstar | Style Box

V B G L M S

Overall Morningstar Rating


Rated against 1244 Large Growth funds as of 05/31/2020
View Morningstar Details

Growth of $10,000 (Hypothetical)

Since Inception 06/28/1996 to 05/31/2020 = $70,323.72

From:
To:
  • 3YR
  • 5YR
  • 10YR
  • INCEP.
INCEP.
  • 3YR
  • 5YR
  • 10YR
  • INCEP.

The performance data shown represents past performance. Past performance is not a guarantee of future results. Current performance may be lower or higher than the performance data quoted. The investment return and the principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. For performance information through the most recent month end please call 800.835.3879. From time to time, the advisor has waived fees or reimbursed expenses, which may have resulted in higher returns. The listed returns and yields of the Fund are net of expenses, and the returns and yields of the indices exclude expenses. For time periods where the fund inception date preceded the benchmark, the benchmark data will not be shown.

View Performance
Read Important Investment Disclosures

Objective

The Fund seeks long-term capital appreciation and current income by investing in the stocks and convertible securities of growth-oriented companies.

Why Consider

  • Invests in common stocks and convertible securities of companies it believes demonstrate high-quality businesses with growth rates that exceed the overall market
  • Consistent risk-controlled approach which includes conservative growth assumptions, position limits based on sectors and individual securities and an explicit sell discipline
  • Team-based fundamental research process utilized to drive investment returns

Documents

View All Documents

Fund Managers

Ronald E. Canakaris, CFA, CIC

Managing Principal and Strategist

Read Full Bio

Andrew W. Jung, CFA

Managing Principal and Director of Investments

Read Full Bio

M. Scott Thompson, CFA

Managing Principal and Director of Research

Read Full Bio

Performance

Performance

Read Important Investment Disclosures

Returns

 

The performance data shown represents past performance. Past performance is not a guarantee of future results. Current performance may be lower or higher than the performance data quoted. The investment return and the principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. For performance information through the most recent month end please call 800.835.3879. From time to time, the advisor has waived fees or reimbursed expenses, which may have resulted in higher returns. The listed returns and yields of the Fund are net of expenses, and the returns and yields of the indices exclude expenses. For time periods where the fund inception date preceded the benchmark, the benchmark data will not be shown. Returns for periods less than one year are not annualized.

Expense Ratios

  • Gross Expense Ratio: 0.99%
  • Net Expense Ratio: 0.99%
  • Expense Cap Expiration Date: N/A

Distributions & Pricing


    • Calendar Year Distributions

    • Ex-Date Total Distribution Income Short-term Cap Gains Long-term Cap Gains
      Dec 16, 2019 $1.695900 — — $1.695900
      Dec 27, 2018 $3.921700 $0.026500 $0.450300 $3.444900
      Dec 27, 2017 $1.959400 $0.019700 — $1.939700
      Dec 27, 2016 $2.087000 $0.132600 — $1.954400
      Dec 30, 2015 $6.910100 $0.156900 — $6.753200
      Dec 30, 2014 $5.182000 $0.179300 $0.203300 $4.799400
      Dec 30, 2013 $2.198900 $0.235700 $0.050000 $1.913200
      Dec 28, 2012 $1.988000 $0.281500 $0.063700 $1.642800
      Dec 29, 2011 $2.072100 $0.191000 — $1.881100
      Dec 29, 2010 $0.227200 $0.186500 — $0.040700
      Dec 29, 2009 $0.117300 $0.117300 — —
      Dec 29, 2008 $0.708000 $0.110900 — $0.597100
      Dec 14, 2007 $4.098100 $0.072200 $0.556300 $3.469600
      Sep 14, 2007 $0.048400 $0.048400 — —
      Mar 16, 2007 $0.036300 $0.036300 — —
      Dec 15, 2006 $0.225813 $0.050800 — $0.175013
      Sep 15, 2006 $0.026200 $0.026200 — —
      Jun 16, 2006 $0.021800 $0.021800 — —
      Mar 10, 2006 $0.030000 $0.030000 — —
      Dec 16, 2005 $0.075100 $0.075100 — —
      Sep 16, 2005 $0.013800 $0.013800 — —
      Jun 10, 2005 $0.025000 $0.025000 — —
      Mar 11, 2005 $0.020000 $0.020000 — —
      Dec 17, 2004 $0.051000 $0.051000 — —
      Sep 10, 2004 $0.025000 $0.025000 — —
      Jun 14, 2004 $0.020000 $0.020000 — —
      Mar 12, 2004 $0.022600 $0.022600 — —
      Dec 19, 2003 $0.035800 $0.035800 — —
      Sep 12, 2003 $0.034700 $0.034700 — —
      Jun 13, 2003 $0.040100 $0.040100 — —
      Mar 14, 2003 $0.029600 $0.029600 — —
      Dec 20, 2002 $0.060400 $0.060400 — —
      Sep 13, 2002 $0.040000 $0.040000 — —
      Jun 14, 2002 $0.035000 $0.035000 — —
      Dec 21, 2001 $0.073200 $0.073200 — —
      Sep 20, 2001 $0.070000 $0.070000 — —
      Dec 15, 2000 $4.084300 $0.004400 — $4.079900
      Dec 10, 1999 $1.651300 — — $1.651300
      Dec 11, 1998 $0.935900 — — $0.935900
      Dec 12, 1997 $0.211800 — — $0.211800
      Jun 13, 1997 $0.002500 $0.002500 — —
      Mar 14, 1997 $0.001700 $0.001700 — —
      Dec 13, 1996 $0.136800 — — $0.136800
      Sep 13, 1996 $0.016200 $0.016200 — —
  • From:
    To:

Risk & Return Stats

As of: 05/31/2020

View All Characteristics & Stats

Portfolio & Holdings

Portfolio & Holdings

Top Holdings (Equity)

As of: 03/31/2020

Microsoft Corp 6.46%
Alphabet Inc, Class A 5.12%
Apple Inc 4.66%
Facebook Inc, Class A 4.42%
Visa Inc, Class A 4.34%
UnitedHealth Group Inc 4.07%
Salesforce.com Inc 3.94%
Abbott Laboratories 3.93%
Thermo Fisher Scientific Inc 3.86%
Mondelez International Inc, Class A 3.76%
% in Top 10 Holdings 44.56%
View Holding Details Read Important Investment Disclosures

Sector Allocation (Equity)

As of: 03/31/2020

View Allocation Details

Investment Approach

Investment Approach

Montag & Caldwell Growth Fund

The Fund primarily invests in the common stocks, convertible preferred stocks and convertible bonds of large cap companies. The Fund defines a large cap company as having a market capitalization of $5 billion or more at the time of acquisition. The Fund seeks companies selling at a discount to their intrinsic value, and targets companies which it believes:

  • Have a strong history of earnings growth
  • Are attractively priced, relative to the company’s potential for above average long-term earnings and revenue growth
  • Have strong balance sheets
  • Have a sustainable competitive advantage
  • Are currently, or have the potential to become, industry leaders
  • Have the potential to outperform during market downturns

Additional Fund Highlight

Consistent and disciplined process through full market cycle.


Keep Calm and Remain Diversified

 
A short- and long-term review of the power of diversification.
Read Full Perspective

  Read Full Perspective

About

About Montag & Caldwell

Background

Montag & Caldwell uses a disciplined team-based fundamental research process that seeks to invest in growth companies.

Learn More

Founded

1945

Headquarters

Atlanta, GA

Funds to Consider

YACKX

Yacktman Fund

The Fund seeks long-term capital appreciation and, to a lesser extent, current income by primarily investing in common stocks of U.S. companies.

Overall Morningstar Rating

Rated against 1108 Large Value funds as of 05/31/2020
★★★★★
■YACKX
■S&P 500 Index
■Russell 1000® Value Index

Quarterly performance (%) data as of 03/31/2020

Fund Detail Read Important Investment Disclosures

TYWVX

GW&K Emerging Wealth Equity Fund

Seeks to provide long-term capital appreciation by investing in emerging market companies and developed market companies that have emerging markets revenue exposure.

Overall Morningstar Rating

Rated against 700 Diversified Emerging Mkts funds as of 05/31/2020
★★★★★
■TYWVX
■MSCI Emerging Markets Index

Quarterly performance (%) data as of 03/31/2020

Fund Detail Read Important Investment Disclosures

HLMNX

Harding Loevner International Equity Portfolio

The Portfolio seeks long-term capital appreciation through investments in equity securities of companies based outside the United States.

Overall Morningstar Rating

Rated against 419 Foreign Large Growth funds as of 05/31/2020
★★★
■HLMNX
■MSCI ACWI ex USA Index

Quarterly performance (%) data as of 03/31/2020

Fund Detail Read Important Investment Disclosures

Discover how AMG Funds brings more than 70 products from over 25 independent boutiques together under one flag.

Learn More About AMG Funds

Morningstar Ratings


Risk-adjusted returns as of 05/31/2020

Overall Rating    (of 1244)
3 Years    (of  1244)
5 Years    (of  1084)
10 Years    (of  814)
Category Large Growth

Read Important Investment Disclosures

  Back To Top

You Are Now Leaving The AMG Funds Website:

You are now leaving the AMG Funds web site: The link you have selected is located on another web site. Please click OK below to leave the AMG Funds site and proceed to the selected site. AMG Funds does not endorse this web site, its sponsor, or any of the policies, activities, products or services offered on the site, or by any advertiser on the site. AMG Funds has no control of the content or data shown on this site, and while AMG Funds has no reason to doubt the reliability of the data shown, its accuracy is not guaranteed. Furthermore, AMG Funds takes no responsibility for the accuracy or factual correctness of any information posted to third party web sites.

Thank you for your interest in AMG Funds.

OK